These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9888625)

  • 1. Abuse liability of flunitrazepam among methadone-maintained patients.
    Farré M; Terán MT; Roset PN; Mas M; Torrens M; Camí J
    Psychopharmacology (Berl); 1998 Dec; 140(4):486-95. PubMed ID: 9888625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers.
    Farré M; Terán MT; Camí J
    Psychopharmacology (Berl); 1996 May; 125(1):1-12. PubMed ID: 8724443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers.
    Mintzer MZ; Griffiths RR
    Behav Pharmacol; 2005 Nov; 16(7):579-84. PubMed ID: 16170235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
    Cami J; Farré M; Mas M; Roset PN; Poudevida S; Mas A; San L; de la Torre R
    J Clin Psychopharmacol; 2000 Aug; 20(4):455-66. PubMed ID: 10917407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
    Mintzer MZ; Griffiths RR
    Drug Alcohol Depend; 1998 Dec; 53(1):49-66. PubMed ID: 10933340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
    J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.
    Heil SH; Holmes HW; Bickel WK; Higgins ST; Badger GJ; Laws HF; Faries DE
    Drug Alcohol Depend; 2002 Jul; 67(2):149-56. PubMed ID: 12095664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of subjective, psychomotor and physiological effects of a novel muscarinic analgesic, LY297802 tartrate, and oral morphine in occasional drug users.
    Petry NM; Bickel WK; Huddleston J; Tzanis E; Badger GJ
    Drug Alcohol Depend; 1998 Apr; 50(2):129-36. PubMed ID: 9649964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
    Lintzeris N; Mitchell TB; Bond AJ; Nestor L; Strang J
    Drug Alcohol Depend; 2007 Dec; 91(2-3):187-94. PubMed ID: 17624687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse liability assessment of sibutramine, a novel weight control agent.
    Schuh LM; Schuster CR; Hopper JA; Mendel CM
    Psychopharmacology (Berl); 2000 Jan; 147(4):339-46. PubMed ID: 10672626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males.
    Roset PN; Farré M; de la Torre R; Mas M; Menoyo E; Hernández C; Camí J
    Drug Alcohol Depend; 2001 Nov; 64(3):285-98. PubMed ID: 11672943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects.
    Berlin I; Warot D; Aymard G; Acquaviva E; Legrand M; Labarthe B; Peyron I; Diquet B; Lechat P
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):447-55. PubMed ID: 11699608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial.
    Wickens CM; Wright M; Mann RE; Brands B; Di Ciano P; Stoduto G; Fares A; Matheson J; George TP; Rehm J; Shuper PA; Sproule B; Samohkvalov A; Huestis MA; Le Foll B
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110570. PubMed ID: 35551928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of triazolam and flunitrazepam--two benzodiazepines with different half-lives--on breathing during sleep.
    Schneider H; Grote L; Peter JH; Cassel W; Guilleminault C
    Chest; 1996 Apr; 109(4):909-15. PubMed ID: 8635369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
    Mitchell TB; Dyer KR; Newcombe D; Salter A; Somogyi AA; Bochner F; White JM
    Br J Clin Pharmacol; 2004 Dec; 58(6):609-17. PubMed ID: 15563359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.